Xenograft with or Without Erythropoietin in Immediate Dental Implant (NCT06601400) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Xenograft with or Without Erythropoietin in Immediate Dental Implant
Egypt24 participantsStarted 2024-09-14
Plain-language summary
The aim of this study is to evaluate changes in buccal bone thickness after immediate implant placement with xenograft mixed with erythropoietin in the anterior maxilla with a thin buccal bone
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
* Inclusion criteria
* Adult (≥18 years) with non-restorable maxillary teeth in the esthetic zone (upper right second premolar to upper left second premolar).
* Intact with thin labial plate of bone (≤1mm).
* The recipient site of the implant should be free from any pathological conditions.
* Patients who are cooperative, motivated and hygiene conscious.
* Appropriate crown height space to maintain favorable crown : implant ratio
* Exclusion criteria
* Systemic conditions/diseases that contraindicate surgery.
* Patients who have any habits that might jeopardize the osseointegration process, such as current smokers.
* Patients with parafunctional habits that produce overload on implant, such as bruxism and clenching.
* Patients with periodontal disease.
* Alcohol or drug abuse.
* Pregnant and lactating women.